Advertisement
U.S. Markets closed
S&P Futures
5,964.00 +5.75 (+0.10%) Dow Futures
43,986.00 +85.00 (+0.19%) Nasdaq Futures
20,915.00 +21.00 (+0.10%) Russell 2000 Futures
2,409.80 +4.00 (+0.17%) Crude Oil
72.12 +0.43 (+0.60%) Gold
2,664.80 -11.50 (-0.43%)
Regeneron Pharmaceuticals, Inc. (REGN.MX)
Mexico - Mexico Delayed Price. Currency in MXN
Follow
At close: 02:33PM CST
Currency in MXN
Valuation Measures4
| Market Cap (intraday) | 1.83T |
| Enterprise Value | 1.69T |
| Trailing P/E | 20.99 |
| Forward P/E | 18.62 |
| PEG Ratio (5 yr expected) | 1.25 |
| Price/Sales (ttm) | 7.05 |
| Price/Book (mrq) | 3.18 |
| Enterprise Value/Revenue | 6.07 |
| Enterprise Value/EBITDA | 15.28 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.12 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 23,707.11 |
| 52 Week Low 3 | 13,696.61 |
| 50-Day Moving Average 3 | 20,620.39 |
| 200-Day Moving Average 3 | 18,372.70 |
Share Statistics
| Avg Vol (3 month) 3 | 97 |
| Avg Vol (10 day) 3 | 163 |
| Shares Outstanding 5 | 108.07M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 103.1M |
| % Held by Insiders 1 | 1.56% |
| % Held by Institutions 1 | 91.78% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Sep 30, 2024 |
Profitability
| Profit Margin | 33.61% |
| Operating Margin (ttm) | 33.21% |
Management Effectiveness
| Return on Assets (ttm) | 7.35% |
| Return on Equity (ttm) | 17.17% |
Income Statement
| Revenue (ttm) | 13.85B |
| Revenue Per Share (ttm) | 128.69 |
| Quarterly Revenue Growth (yoy) | 10.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | 4.56B |
| Net Income Avi to Common (ttm) | 4.65B |
| Diluted EPS (ttm) | 812.79 |
| Quarterly Earnings Growth (yoy) | 33.00% |
Balance Sheet
| Total Cash (mrq) | 9.8B |
| Total Cash Per Share (mrq) | 91.05 |
| Total Debt (mrq) | 2.7B |
| Total Debt/Equity (mrq) | 9.22 |
| Current Ratio (mrq) | 5.28 |
| Book Value Per Share (mrq) | 272.04 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.25B |
| Levered Free Cash Flow (ttm) | 2.22B |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.